Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU)

Main Article Content

Gordon Sussman
Jacques Hebert
Wayne Gulliver
Charles Lynde
William H Yang
Olivier Chambenoit
Gretty Deutsch
Frederica DeTakacsy
Lenka Rihakova

Keywords

urticaria, omalizumab, chronic urticaria, biologic therapy

Abstract

Abstract Not Available